These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 14242275)

  • 1. [BETAIN NICOTINATE IN PROLONGED ORAL FIBRINOLYTIC THERAPY].
    FRANDOLI G; GIBELLI A; TURAZZA G
    Gazz Int Med Chir; 1964 Nov; 68():2065-83. PubMed ID: 14242275
    [No Abstract]   [Full Text] [Related]  

  • 2. [FIBRINOLYTIC CHEMOTHERAPY. FIRST RESULTS OF A PERSONAL EXPERIENCE].
    PERRIN A; FONTAINE L; SAINT-PIERRE A
    Lyon Med; 1964 Dec; 212():1551-60. PubMed ID: 14253644
    [No Abstract]   [Full Text] [Related]  

  • 3. STUDIES WITH COMPLAMIN, A NICOTINIC-ACID-THEOPHYLLINE ESTER, AS A FIBRINOLYTIC AGENT.
    MCNICOL GP; DOUGLAS AS
    Br Med J; 1965 May; 1(5443):1149-53. PubMed ID: 14273517
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of nicotinic acid on the fibrinolytic activity of the blood in atherosclerosis].
    SHERSHEVSKII MG
    Kardiologiia; 1963; 3():64-8. PubMed ID: 13977201
    [No Abstract]   [Full Text] [Related]  

  • 5. EFFECT OF NICOTINIC ACID ON FIBRINOLYTIC ACTIVITY OF THE BLOOD IN ATHEROSCLEROSIS.
    SHERSHEVSKII MG
    Fed Proc Transl Suppl; 1963; 22():1154-6. PubMed ID: 14079323
    [No Abstract]   [Full Text] [Related]  

  • 6. TREATMENT OF PARKINSONISM IN ELDERLY PATIENTS WITH COSALDON.
    MUSTARD DM
    Br J Clin Pract; 1964 Sep; 18():537-8. PubMed ID: 14207669
    [No Abstract]   [Full Text] [Related]  

  • 7. [FIBRINOLYSIS, THROMBOLYSIS AND FIBRINOLYTIC TREATMENT].
    STOICHITA M
    Med Interna (Bucur); 1964 Oct; 16():1163-72. PubMed ID: 14244194
    [No Abstract]   [Full Text] [Related]  

  • 8. [7-(3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL)-1,3-DIMETHYL-XANTHINE NICOTINATE IN ADVANCED VASCULAR DISEASES].
    FEUNEDECOLOMBI G; SCIARROTTA NO; DUSSAUT A
    Sem Med; 1963 Jul; 123():17-22. PubMed ID: 14084888
    [No Abstract]   [Full Text] [Related]  

  • 9. A LONG TERM STUDY OF THE EFFECT OF NICOTINIC ACID MEDICATION ON HYPERCHOLESTEREMIA.
    LANGE K; MAHL M
    Am J Med Sci; 1963 Dec; 246():673-7. PubMed ID: 14085222
    [No Abstract]   [Full Text] [Related]  

  • 10. CURRENT STATUS OF THROMBOLYTIC THERAPY.
    SHERRY S
    Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinolytic action of nicotinic acid].
    MARRAZZA P; LUCA S
    Acta Vitaminol; 1960 Oct; 14():207-9. PubMed ID: 13767111
    [No Abstract]   [Full Text] [Related]  

  • 12. ALUMINUM NICOTINATE: A HYPOCHOLESTEREMIC AGENT.
    MIALE JP
    Curr Ther Res Clin Exp; 1965 Jun; 7():392-400. PubMed ID: 14317494
    [No Abstract]   [Full Text] [Related]  

  • 13. [INTRA-ARTERIAL BARBITURATE INJECTIONS AND THERAPY OF THEIR CONSEQUENCES].
    KAPFERER JM
    Anaesthesist; 1964 Oct; 13():345. PubMed ID: 14319778
    [No Abstract]   [Full Text] [Related]  

  • 14. [ACTIVATION OF FIBRINOLYSIS BY THE PROLONGED ORAL ADMINISTRATION OF A NICOTINIC DERIVATIVE IN ARTERIOSCLEROTIC SUBJECTS].
    DENICOLA P; FRANDOLI G; GIBELLI A
    G Gerontol; 1963 Oct; 11():955-72. PubMed ID: 14099932
    [No Abstract]   [Full Text] [Related]  

  • 15. [INFLUENCE OF A NICOTINIC ACID DERIVATIVE ON FIBRINOLYTIC PROCESSES].
    PERICOLI F; NUZZI R
    Policlinico Prat; 1963 Nov; 70():1589-95. PubMed ID: 14115994
    [No Abstract]   [Full Text] [Related]  

  • 16. Observations on the use of nicotinic acid to induce in vivo fibrinolytic activity.
    WILSON WL; FOSTIROPOULOS G
    Am J Med Sci; 1959 Nov; 238():591-7. PubMed ID: 13845147
    [No Abstract]   [Full Text] [Related]  

  • 17. [EXPERIENCES WITH THE MEDICAL TREATMENT OF ARTERIOSCLEROSIS OBLITERANS].
    LUCZAK S; BUECHNER H
    Med Klin; 1964 May; 59():738-40. PubMed ID: 14225422
    [No Abstract]   [Full Text] [Related]  

  • 18. [7-(3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL)-1, 3-DIMETHYL-XANTHINE NICOTINATE IN CHRONIC OBLITERATING ANGIOPATHIES].
    FERNANDEZBLANCO E; DEFERNANDEZBLANCO JF; AGUSTINARZENO J
    Sem Med; 1963 Nov; 123():1733-40. PubMed ID: 14110181
    [No Abstract]   [Full Text] [Related]  

  • 19. [COMPARATIVE ANALYSIS OF THE VASCULAR EFFECTS OF 3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL-THEOPHYLLINE NICOTINATE, NICOTINIC ACID AND THEOPHYLLINE].
    DEGREGORIO G; BUDA A; FIDECARO A
    Riforma Med; 1964 Aug; 78():937-41. PubMed ID: 14222308
    [No Abstract]   [Full Text] [Related]  

  • 20. [ON ELECTRORHEOGRAPHIC OBJECTIVE EVALUATION OF SUBSTANCES WITH CENTRAL NERVOUS SYSTEM ACTION. SODIUM NICOTINATE AND SODIUM BETA,BETA-PENTAMETHYLENE-GAMMA-HYDROXYBUTYRATE MONOHYDRATE].
    KUNERT W; DUNKER R
    Arzneimittelforschung; 1963 Nov; 13():986-8. PubMed ID: 14210439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.